What not to mix with semaglutide: the interactions that actually matter

The biggest myth: 'it only affects appetite, so interactions are minimal'

Most people assume a weight-loss medicine works in the gut and stays there. Semaglutide does activate GLP-1 receptors in the gut and brain to reduce appetite, but one of its most clinically relevant effects is slowing how quickly the stomach empties. That matters because dozens of common medicines are absorbed in the stomach or upper small intestine, and delayed gastric emptying can compress or extend their absorption window. The result is not always predictable.

This is not a theoretical risk. The NHS medicines guidance for semaglutide explicitly flags that it may affect the absorption of concomitant oral medicines, and prescribers are asked to monitor patients accordingly. So if anyone has told you that Wegovy 'does not interact with other drugs', that is not an accurate picture. The interactions are real; they are manageable; and catching them before you start is the point.

The NHS patient-level guidance on semaglutide on the NHS medicines pages is a good first read before any clinic appointment.

Oral medicines where timing and monitoring matter most

Warfarin and other anticoagulants sit at the top of this list. Warfarin has a narrow therapeutic window, a small change in absorption can push the INR out of range in either direction. If you take warfarin and are considering Wegovy, your anticoagulation monitoring may need to be more frequent when treatment starts and after each dose change.

Thyroid replacement therapy (levothyroxine) is another common one. Many patients take it first thing in the morning, tablet left on the bedside table or kept in a bedside drawer, swallowed before the kettle even goes on. Semaglutide does not appear to significantly alter levothyroxine levels in most people, but because the mechanism of interaction exists, thyroid function should be checked if symptoms change.

Antiepileptics and immunosuppressants used after transplant are further examples where absorption consistency is clinically important. Your prescriber needs to know about all regular oral medicines before approving treatment. That review is part of the clinical assessment, not an optional extra.

For a fuller picture of what specific medicines require extra care alongside Wegovy, our page on medicines you cannot take with semaglutide goes into individual drug classes in detail.

Oral contraceptives, hormones and what current guidance actually says

This is the area where UK guidance is most specific. Semaglutide can reduce the rate of absorption of oral contraceptives, particularly combined pills. NHS England's weight-management-injections guidance recommends that women using oral contraceptives discuss this with their prescriber before starting any GLP-1 medicine.

For tirzepatide (Mounjaro), the guidance is clearer still: add a non-oral method of contraception for the first four weeks of treatment and for four weeks after each dose increase. For semaglutide specifically, the evidence is less definitive, but the precautionary recommendation to discuss pill use before starting stands. Switching to a patch, implant or coil removes the absorption question entirely for the duration of treatment.

HRT is a related consideration. Oral HRT preparations involve the same absorption pathway, so if you take oral oestrogen you may want to discuss transdermal options with your GP. Patches and gels bypass the gut entirely. None of this means you cannot take semaglutide alongside contraception or HRT, it means the form you use is worth reviewing, as NHS England's guidance on weight-management injections sets out clearly.

If you are also interested in what broader lifestyle habits to avoid while on Wegovy, there is practical detail on our page covering what not to do on Wegovy.

Alcohol, other GLP-1 combinations and common questions

Alcohol has no direct pharmacokinetic interaction with semaglutide, but context makes it relevant. If you also take insulin or a sulphonylurea for type 2 diabetes, alcohol raises hypoglycaemia risk and semaglutide amplifies that in some patients by changing meal timing and appetite. Practical advice: eat before drinking, keep portions modest, and make sure the people around you know the signs of a hypo.

Combining semaglutide with another GLP-1 medicine is not recommended, there is no licensed rationale and the additive GI side-effect burden would be considerable. Similarly, using compounded or unlicensed semaglutide preparations alongside a licensed product is not safe and is not something a GPhC-registered prescriber will sanction.

One question our prescribers hear regularly: can you take over-the-counter painkillers? Ibuprofen and other NSAIDs are not directly contraindicated, but they can irritate the stomach lining, and when nausea is already present that combination is uncomfortable at best and problematic for people prone to gastric issues. Paracetamol is the usual recommendation for mild pain during the early weeks, and if you want a comprehensive guide to what else to avoid, our page on what not to take with Wegovy covers the full range of medicines and supplements to be cautious about. Always defer to your patient information leaflet and prescriber on this.

If GI symptoms like bloating are a concern, it is worth reading about excessive gas on Wegovy, a practical overview of what is common and when to seek advice. For a broader overview of the treatment itself, our Wegovy information page covers how it works and what the clinical evidence shows.

Cost context is a reasonable question too: if you are weighing up starting privately, our overview of Wegovy pricing in the UK explains what private treatment realistically costs and what a legitimate service includes. When you are ready to take the next step, start your free consultation and a GPhC-registered prescriber will review your full medicines list as part of the process.